Market Cap

CollPlant Biotechnologies Ltd. Market Capitalization:

$18.9 Million

USD as of Jan. 1, 2026

business CollPlant Biotechnologies Ltd. Company Profile

CollPlant Biotechnologies Ltd. Main Stock Listing

NASDAQ: CLGN

Market Capitalization History of CollPlant Biotechnologies Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of CollPlant Biotechnologies Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $18.9 M -55.50%
Jan. 1, 2025 $42.5 M -39.67%
Jan. 1, 2024 $70.4 M -25.56%
Jan. 1, 2023 $94.6 M -1.43%
Jan. 1, 2022 $96.0 M -46.10%
Jan. 1, 2021 $178.1 M 73.36%
Jan. 1, 2020 $102.7 M 75.17%
Jan. 1, 2019 $58.6 M -32.96%
Jan. 1, 2018 $87.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

CollPlant Biotechnologies Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

CollPlant Biotechnologies Ltd. has the following listings and related stock indices.


Stock: NASDAQ: CLGN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.